SolarEdge rockets 17.94% today on analyst upgrades ahead of earnings today after the close

SolarEdge rockets 17.94% today on analyst upgrades ahead of earnings today after the close

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Raising target on Barrick Gold in Jubak Picks Portfolio and buying the shares for my Dividend Portfolio

Raising target on Barrick Gold in Jubak Picks Portfolio and buying the shares for my Dividend Portfolio

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Adding Bargain Pick #11 Wesco International to Jubak Picks

Adding Bargain Pick #11 Wesco International to Jubak Picks

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Good news in yesterday’s U.S.-China trade deal for Visa, MasterCard, and American Express

Good news in yesterday’s U.S.-China trade deal for Visa, MasterCard, and American Express

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

FDA and Nektar both shock on company’s opioid drug candidate; I’d buy more on weakness

FDA and Nektar both shock on company’s opioid drug candidate; I’d buy more on weakness

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

FDA and Nektar both shock on company’s opioid drug candidate; I’d buy more on weakness

Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200